These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8532928)

  • 21. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
    Oxenius A; Price DA; Hersberger M; Schlaepfer E; Weber R; Weber M; Kundig TM; Böni J; Joller H; Phillips RE; Flepp M; Opravil M; Speck RF;
    J Infect Dis; 2004 Apr; 189(7):1199-208. PubMed ID: 15031788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling the strands of HIV's web.
    Pantaleo G
    Nat Med; 1999 Jan; 5(1):27-8. PubMed ID: 9883835
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
    Kolber MA
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1002-7. PubMed ID: 15539497
    [No Abstract]   [Full Text] [Related]  

  • 27. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunobiology of HIV infection].
    Hattori T
    Uirusu; 2002 Dec; 52(2):245-9. PubMed ID: 12685315
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant.
    Sabbaj S; Ibegbu CC; Kourtis AP
    Adv Exp Med Biol; 2012; 743():161-9. PubMed ID: 22454348
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immune control of HIV-infection and replication].
    Matsushita S
    Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV-1 elite controllers: beware of super-infections.
    Clerc O; Colombo S; Yerly S; Telenti A; Cavassini M
    J Clin Virol; 2010 Apr; 47(4):376-8. PubMed ID: 20153976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.
    Blish CA; Dogan OC; Jaoko W; McClelland RS; Mandaliya K; Odem-Davis KS; Richardsonb BA; Overbaugh J
    AIDS; 2012 Mar; 26(5):643-6. PubMed ID: 22210637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Questions about CD8+ anti-HIV lymphocytes in the control of HIV infection.
    Levy JP
    Antibiot Chemother (1971); 1996; 48():13-20. PubMed ID: 8726501
    [No Abstract]   [Full Text] [Related]  

  • 34. [HIV infection and spontaneous control of the infection].
    Lambotte O
    Rev Med Interne; 2007 Apr; 28(4):203-5. PubMed ID: 17137682
    [No Abstract]   [Full Text] [Related]  

  • 35. Changing virus-host interactions in the course of HIV-1 infection.
    Miedema F; Meyaard L; Koot M; Klein MR; Roos MT; Groenink M; Fouchier RA; Van't Wout AB; Tersmette M; Schellekens PT
    Immunol Rev; 1994 Aug; 140():35-72. PubMed ID: 7821927
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular immune responses to HIV-1 in progressive and non-progressive infections.
    Bollinger RC; Egan MA; Chun TW; Mathieson B; Siliciano RF
    AIDS; 1996; 10 Suppl A():S85-96. PubMed ID: 8883615
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the study power enough to say "no difference"?
    Geib G; Debiasi M; Barcellos NT; Wolff FH
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):e37; author reply e37-8. PubMed ID: 21921724
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of HIV-1 disease.
    Smith KJ; Skelton HG; Wagner KF
    Int J Dermatol; 1995 May; 34(5):308-18. PubMed ID: 7607789
    [No Abstract]   [Full Text] [Related]  

  • 39. Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants.
    Kostense S; Krop E; Blaak H; Schuitemaker H; Miedema F
    AIDS; 2000 Feb; 14(3):330-1. PubMed ID: 10716514
    [No Abstract]   [Full Text] [Related]  

  • 40. Duesberg and the new view of HIV.
    Maddox J
    Nature; 1995 Jan; 373(6511):189. PubMed ID: 7816122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.